Author

R. Penya

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:flow cytometry· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Approach:statistical model· 1

Frequent Co-Authors

B. Clotet· 2 shared D. Ouchi· 2 shared E. Jimenez-Moyano· 2 shared O. Blanch-Lombarte· 2 shared A. Chamorro· 1 shared A. Kilpelainen· 1 shared A. Pelletier· 1 shared A. Sharma· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

B. Clotet

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Selective loss of CD107a TIGIT+ memory HIV-1-specific CD8+ T cells in PLWH over a decade of ART

O. Blanch-Lombarte, D. Ouchi, E. Jimenez-Moyano, J. Carabelli, M. A. Marin, R. Penya, A. Pelletier, A. Talla, A. Sharma, J. Dalmau, J. R. Santos, R.-P. A. Sekaly, B. Clotet, J. G. Prado

This study identifies a selective loss of CD107a+ TIGIT+ memory HIV-1-specific CD8+ T cells in PLWH on long-term ART, which can be reversed by TIGIT blockade.

bioRxiv · Jul 13, 2022Immunology

Highly functional Cellular Immunity in SARS-CoV-2 Non-Seroconvertors is associated with immune protection

A. Kilpelainen, E. Jimenez-Moyano, O. Blanch-Lombarte, D. Ouchi, R. Penya, B. Quirant-Sanchez, A. Chamorro, I. Blanco, E. Martinez-Caceres, R. Paredes, L. Mateu, J. Carrillo, J. Blanco, C. Brander, M. Massanella, , J. G Prado

The paper examines T-cell immunity in SARS-CoV-2 non-seroconvertors, finding high functional T-cell responses and low immune activation correlate with protection from severe disease without seroconversion.

bioRxiv · May 4, 2021 · PreprintImmunology